Local leptin production in osteoarthritis subchondral osteoblasts may be responsible for their abnormal phenotypic expression

Arthritis Research and Therapy

Volumn 12, Issue 1, 2010, Pages

  Mutabaruka, Marie Solange ^a   Aoulad Aissa, Mohamed ^a   Delalandre, Aline ^a   Lavigne, Martin ^b   Lajeunesse, Daniel ^a  

^a NOTRE DAME HOSPITAL   (Canada)

^b MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BIOLOGICAL MARKER; COLLAGEN TYPE 1; LEPTIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; OSTEOCALCIN; PICEATANNOL; PROTEIN P42; PROTEIN P44; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA; LEPTIN RECEPTOR;

ADULT; AGED; ARTICLE; AUTOPSY; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; HORMONE SYNTHESIS; HUMAN; HUMAN TISSUE; IN VITRO STUDY; KNEE SURGERY; OSTEOARTHRITIS; OSTEOBLAST; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TIBIA; WESTERN BLOTTING; BIOSYNTHESIS; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; METABOLISM; PHYSIOLOGY;

AGED; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LEPTIN; OSTEOARTHRITIS; OSTEOBLASTS; PHENOTYPE; RECEPTORS, LEPTIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 77955176027     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2925     Document Type: Article

References (65)

1. Poole AR. Cartilage in health and disease. Arthritis and Allied Conditions: a Textbook of Rheumatology 1997, 255-308. Baltimore: Williams & Wilkins, Koopman WJ.
2. Hamerman D. The biology of osteoarthritis. N Engl J Med 1989, 320:1322-1330.
3. Davis MA. Epidemiology of osteoarthritis. Clin Geriatr Med 1988, 4:241-255.
4. Felson DT, Anderson JJ, Naimark A, Walker AM, Meenan RF. Obesity and knee osteoarthritis. Ann Intern Med 1988, 109:18-24.
5. Foss MVL, Byers PD. Bone density, osteoarthrosis of the hip and fracture of the upper end of the femur. Ann Rheum Dis 1972, 31:259-264. 1005923, 5045904.
6. Roh YS, Dequeker J, Muiler JC. Bone mass is osteoarthrosis, measured in vivo by photon absorption. J Bone Joint Surg Am 1974, 56:587-591.
7. Mokassa Bakumobatane L, Dequeker J, Raymaekers G, Aerssens J. Effects of osteoarthritis (OA) and body weight on subchondral cancellous bone quality of proximal tibia. Osteoarthritis Cart 1993, 1:55-56.
8. Sharif M, George E, Dieppe PA. Correlation between synovial fluid markers of cartilage and bone turnover and scintigraphic scan abnormalities in osteoarthritis of the knee. Arthritis Rheum 1995, 38:78-81.
9. Gevers G, Dequeker J. Collagen and non-collagenous protein content (osteocalcin, sialoprotein, proteoglycan) in the iliac crest bone and serum osteocalcin in women with and without hand osteoarthritis. Coll Relat Res 1987, 7:435-442.
10. Dequeker J, Mohan R, Finkelman RD, Aerssens J, Baylink DJ. Generalized osteoarthritis associated with increased insulin-like growth factor types I and II and transforming growth factor beta in cortical bone from the iliac crest. Possible mechanism of increased bone density and protection against osteoporosis. Arthritis Rheum 1993, 36:1702-1708.
11. Hilal G, Martel-Pelletier J, Pelletier JP, Ranger P, Lajeunesse D. Osteoblast-like cells from human subchondral osteoarthritic bone demonstrate an altered phenotype in vitro: Possible role in subchondral bone sclerosis. Arthritis Rheum 1998, 41:891-899.
12. Massicotte F, Lajeunesse D, Benderdour M, Pelletier J-P, Hilal G, Duval N, Martel-Pelletier J. Can altered production of interleukin 1β, interleukin-6, transforming growth factor-β and prostaglandin E2 by isolated human subchondral osteoblasts identify two subgroups of osteoarthritic patients. Osteoarthritis Cartilage 2002, 10:491-500.
13. Zhang Y, Procenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372:425-432.
14. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse OB-protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995, 269:546-549.
15. Masuzaki M, Ogawa Y, Sagawa N, Hosoda K, Matsumoto T, Mise H, Nishimura H, Yoshimasa Y, Tanaka I, Mori T, Nakao K. Nonadipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans. Nature Medicine 1997, 3:1029-1033.
16. Reseland JE, Syversen U, Bakke I, Qvigstad G, Eide LG, Hjertner O, Gordeladze JO, Drevon CA. Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization. J Bone Miner Res 2001, 16:1426-1433.
17. Lee YJ, Park JH, Ju SK, You KH, Ko JS, Kim HM. Leptin receptor isoform expression in rat osteoblasts and their functional analysis. FEBS Lett 2002, 528:43-47.
18. Gainsford T, Willson TA, Metcalf D, Handman E, McFarlane C, Ng A, Nicola NA, Alexander WS, Hilton DJ. Leptin can induce proliferation, differentiation, and functional activation of hematopoietic cells. Proc Natl Acad Sci U S A 1996, 93:14564-14568.
19. Siegrist-Kaiser CA, Pauli V, Juge-Aubry CE, Boss O, Pernin A, Chin WW, Cusin I, Rohner-Jeanrenaud F, Burger AG, Zapf J, Meier CA. Direct effects of leptin on brown and white adipose tissue. J Clin Invest 1997, 100:2858-2864. 508492, 9389752.
20. Shimabukuro M, Koyama K, Chen G, Wand MY, Trieu F, Lee Y, Newgard CB, Unger RH. Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc Natl Acad Sci USA 1997, 94:4637-4641. 20776, 9114043.
21. Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, Richards GJ, Campfield LA, Clark FT, Deeds J, Muir C, Sanker S, Moriarty A, Moore KJ, Smutko JS, Mays GG, Woolf EAMCA, Tepper RI. Identification and Expression Cloning of a Leptin Receptor, OB-R. Cell 1995, 83:1263-1271.
22. El-Haschimi K, Pierroz DD, Hileman SM, Bjorbaek C, Flier JS. Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. J Clin Invest 2000, 105:1827-1832. 378516, 10862798.
23. Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker KL, Armstrong D, Ducy P, Karsenty G. Leptin regulates bone formation via the sympathetic nervous system. Cell 2002, 111:305-317.
24. Ducy P, Amling M, Takeda S, Prieme M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM, Karsenty G. Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass. Cell 2000, 100:197-207.
25. Vignolo M, Naselli A, Di Battista E, Mostert M, Aicardi G. Growth and development in simple obesity. Eur J Pediatr 1988, 147:242-244.
26. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996, 334:292-295.
27. Maor G, Rochwerger M, Segev Y, Phillip M. Leptin acts as a growth factor on the chondrocytes of skeletal growth centers. J Bone Miner Res 2002, 17:1034-1043.
28. Thomas T, Burguera B. Is leptin the link between fat and bone mass?. J Bone Miner Res 2002, 17:1563-1569.
29. Reseland JE, Gordeladze JO. Role of leptin in bone growth: central player or peripheral supporter?. FEBS Letters 2002, 528:40-42.
30. Kalra SP, Dube MG, Iwaniec UT. Leptin increases osteoblast-specific osteocalcin release through a hypothalamic relay. Peptides 2009, 30:967-973.
31. Bertoni L, Ferretti M, Cavani F, Zavatti M, Resca E, Benelli A, Palumbo C. Leptin increases growth of primary ossification centers in fetal mice. J Anat 2009, 215:577-583.
32. Wlodarski K, Wlodarski P. Leptin as a modulator of osteogenesis. Ortop Traumatol Rehabil 2009, 11:1-6.
33. Gordeladze JO, Reseland JE. A unified model for the action of leptin on bone turnover. Journal of Cellular Biochemistry 2003, 88:706-712.
34. Iwaniec UT, Dube MG, Boghossian S, Song H, Helferich WG, Turner RT, Kalra SP. Body mass influences cortical bone mass independent of leptin signaling. Bone 2009, 44:404-412.
35. Steppan CM, Crawford DT, Chidsey-Frink KL, Ke HZ, Swick AG. Leptin is a potent stimulator of bone growth in ob/ob mice. Regulatory Peptides 2000, 92:73-78.
36. Gordeladze JO, Drevon CA, Syversen U, Reseland JE. Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: Impact on differentiation markers, apoptosis, and osteoclastic signaling. J Cell Biochem 2002, 85:825-836.
37. Dumond H, Presle N, Terlain B, Mainard D, Loeuille D, Netter P, Pottie P. Evidence for a key role of leptin in osteoarthritis. Arthritis Rheum 2003, 48:3118-3129.
38. Simopoulou T, Malizos KN, Iliopoulos D, Stefanou N, Papatheodorou L, Ioannou M, Tsezou A. Differential expression of leptin and leptin's receptor isoform (Ob-Rb) mRNA between advanced and minimally affected osteoarthritic cartilage; effect on cartilage metabolism. Osteoarthritis Cartilage 2007, 15:872-883.
39. Ku JH, Lee CK, Joo BS, An BM, Choi SH, Wang TH, Cho HL. Correlation of synovial fluid leptin concentrations with the severity of osteoarthritis. Clin Rheumatol 2009, 28:1431-1435.
40. Hilal G, Massicotte F, Martel-Pelletier J, Fernandes JC, Pelletier JP, Lajeunesse D. Endogenous prostaglandin E2 and insulin-like growth factor 1 can modulate the levels of parathyroid hormone receptor in human osteoarthritic osteoblasts. J Bone Miner Res 2001, 16:713-721.
41. Altman RD, Asch E, Bloch DA, Bole G, Borenstein D, Brandt KD, Christy W, Cooke TD, Greenwald R, Hochberg M, Howell DS, Kaplan D, Koopman W, Longley SI, Mankin HJ, McShane DJ, Medsger TA, Meehan R, Mikkelsen W, Moskowitz RW, Murphy W, Rothschild B, Segal L, Sokoloff L, Wolfe F. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Arthritis Rheum 1986, 29:1039-1049.
42. Couchourel D, Aubry I, Delalandre A, Lavigne M, Martel-Pelletier J, Pelletier J-P, Lajeunesse D. Altered Mineralization of Human Osteoarthritic Osteoblasts is due to abnormal collagen type 1 production. Arthritis Rheum 2009, 60:1438-1450.
43. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC. Measurement of protein using Bicinchoninic Acid. Anal Biochem 1985, 150:76-85.
44. Zhao CQ, Liu D, Li H, Jiang LS, Dai LY. Expression of leptin and its functional receptor on disc cells: contribution to cell proliferation. Spine (Phila Pa 1976) 2008, 33:E858-864.
45. Massicotte F, Aubry I, Martel-Pelletier J, Pelletier JP, Fernandes J, Lajeunesse D. Abnormal insulin-like growth factor 1 signaling in human osteoarthritic subchondral bone osteoblasts. Arthritis Res Ther 2006, 8:R177. 1794522, 17129375.
46. Research Services Branch (RSB) Public domain NIH Image program (developed at the U.S. National Institutes of Health). Research Services Branch (RSB)., http://rsb.info.nih.gov/nih-image/
47. Wang J, Liu R, Liu L, Chowdhury R, Barzilai N, Tan J, Rossetti L. The effect of leptin on Lep expression is tissue-specific and nutritionnally regulated. Nat Med 1999, 5:895-899.
48. Imhof H, Breitenseher M, Kainberger F, Rand T, Trattnig S. Importance of subchondral bone to articular cartilage in health and disease. Top Magn Reson Imaging 1999, 10:180-192.
49. Sokoloff L. Microcracks in the calcified layer of articular cartilage. Arch Pathol Lab Med 1993, 117:191-195.
50. Guévremont M, Martel-Pelletier J, Massicotte F, Tardif G, Pelletier J-P, Ranger P, Lajeunesse D, Reboul P. Human adult chondrocytes express hepatocyte growth factor (HGF) isoforms but not HGF. Potential implication of osteoblasts for the HGF presence in cartilage. J Bone Miner Res 2003, 18:1073-1081.
51. Zhang F, Chen Y, Heiman M, Dimarchi R. Leptin: structure, function and biology. Vitam Horm 2005, 71:345-372.
52. Menendez C, Lage M, Peino R, Baldelli R, Concheiro P, Dieguez C, Casanueva FF. Retinoic acid and vitamin D(3) powerfully inhibit in vitro leptin secretion by human adipose tissue. J Endocrinol 2001, 170:425-431.
53. Ben-Eliezer M, Phillip M, Gat-Yablonski G. Leptin regulates chondrogenic differentiation in ATDC5 cell-line through JAK/STAT and MAPK pathways. Endocrine 2007, 32:235-244.
54. Lisignoli G, Toneguzzi S, Piacentini A, Cristino S, Grassi F, Cavallo C, Facchini A. CXCL12 (SDF-1) and CXCL13 (BCA-1) chemokines significantly induce proliferation and collagen type I expression in osteoblasts from osteoarthritis patients. J Cell Physiol 2006, 206:78-85.
55. Kloek C, Haq AK, Dunn SL, Lavery HJ, Banks AS, Myers MG. Regulation of Jak kinases by intracellular leptin receptor sequences. J Biol Chem 2002, 277:41547-41555.
56. Massicotte F, Fernandes JC, Martel-Pelletier J, Pelletier JP, Lajeunesse D. Modulation of insulin-like growth factor 1 levels in human osteoarthritic subchondral bone osteoblasts. Bone 2006, 38:333-341.
57. Cohen B, Novick D, Rubinstein M. Modulation of insulin activities by leptin. Science 1996, 274:1185-1188.
58. Margetic S, Gazzola C, Pegg GG, Hill RA. Leptin: a review of its peripheral actions and interactions. Int J Obes Relat Metab Disord 2002, 26:1407-1433.
59. Niswender KD, Ballis B, Blevins JE, Corson MA, Schwartz MW, Baskin DG. Immunocytochemical detection of phosphatidylinositol 3-kinase activation by insulin and leptin. J Histochem Cytochem 2003, 51:275-283.
60. Figenschau Y, Knutsen G, Shahazeydi S, Johansen O, Sveinbjornsson B. Human articular chondrocytes express functional leptin receptors. Biochem Biophys Res Commun 2001, 287:190-197.
61. Banks AS, Davis SM, Bates SH, Myers MG. Activation of downstream signals by the long form of the leptin receptor. J Biol Chem 2000, 275:14563-14572.
62. Morrison CD, White CL, Wang Z, Lee SY, Lawrence DS, Cefalu WT, Zhang ZY, Gettys TW. Increased hypothalamic protein tyrosine phosphatase 1B contributes to leptin resistance with age. Endocrinology 2007, 148:433-440. 2596872, 17038557.
63. Gualillo O, Eiras S, White DW, Dieguez C, Casanueva FF. Leptin promotes the tyrosine phosphorylation of SHC proteins and SHC association with GRB2. Mol Cell Endocrinol 2002, 190:83-89.
64. Burguera B, Brunetto A, Garcia-Ocana A, Teijeiro R, Esplen J, Thomas T, Couce ME, Zhao A. Leptin increases proliferation of human steosarcoma cells through activation of PI(3)-K and MAPK pathways. Med Sci Monit 2006, 12:BR341-349.
65. Cao Q, Mak KM, Lieber CS. Leptin enhances alpha 1(I) collagen gene expression in LX-2 human hepatic stellate cells through JAK-mediated H2O2-dependent MAPK pathways. J Cell Biochem 2006, 97:188-197.